Hillel S. Ribner

1.3k total citations
25 papers, 1.0k citations indexed

About

Hillel S. Ribner is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Complementary and alternative medicine. According to data from OpenAlex, Hillel S. Ribner has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 5 papers in Complementary and alternative medicine. Recurrent topics in Hillel S. Ribner's work include Heart Failure Treatment and Management (8 papers), Hemodynamic Monitoring and Therapy (6 papers) and Cardiovascular and exercise physiology (5 papers). Hillel S. Ribner is often cited by papers focused on Heart Failure Treatment and Management (8 papers), Hemodynamic Monitoring and Therapy (6 papers) and Cardiovascular and exercise physiology (5 papers). Hillel S. Ribner collaborates with scholars based in United States, Italy and United Kingdom. Hillel S. Ribner's co-authors include Edmund H. Sonnenblick, Thierry H. LeJemtel, Edmund C. Keung, William H. Frishman, Richard C. Davis, Edward S. Eisenberg, Joel A. Strom, William Robson Schwartz, Adawia A. Alousi and Uri Elkayam and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Hillel S. Ribner

25 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hillel S. Ribner United States 14 741 217 127 109 97 25 1.0k
P A Majid Netherlands 19 679 0.9× 351 1.6× 88 0.7× 99 0.9× 64 0.7× 33 1.0k
Andreas P. Niarchos United States 19 680 0.9× 277 1.3× 145 1.1× 48 0.4× 42 0.4× 36 977
John K. Vyden United States 12 464 0.6× 274 1.3× 74 0.6× 68 0.6× 80 0.8× 39 825
W S Hillis United Kingdom 19 534 0.7× 195 0.9× 107 0.8× 82 0.8× 29 0.3× 55 971
Stanley H. Taylor United Kingdom 19 686 0.9× 166 0.8× 53 0.4× 93 0.9× 35 0.4× 61 902
George I. Mallis United States 7 1.4k 1.8× 239 1.1× 319 2.5× 99 0.9× 90 0.9× 10 1.8k
Liv Storstein Norway 20 653 0.9× 77 0.4× 224 1.8× 50 0.5× 70 0.7× 80 1.1k
Joseph R. Benotti United States 16 731 1.0× 193 0.9× 167 1.3× 53 0.5× 73 0.8× 37 1.4k
Terry L. Holcslaw United States 12 1.6k 2.2× 152 0.7× 158 1.2× 124 1.1× 46 0.5× 27 2.1k
B Sigurd Denmark 18 638 0.9× 154 0.7× 136 1.1× 54 0.5× 45 0.5× 49 1.1k

Countries citing papers authored by Hillel S. Ribner

Since Specialization
Citations

This map shows the geographic impact of Hillel S. Ribner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hillel S. Ribner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hillel S. Ribner more than expected).

Fields of papers citing papers by Hillel S. Ribner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hillel S. Ribner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hillel S. Ribner. The network helps show where Hillel S. Ribner may publish in the future.

Co-authorship network of co-authors of Hillel S. Ribner

This figure shows the co-authorship network connecting the top 25 collaborators of Hillel S. Ribner. A scholar is included among the top collaborators of Hillel S. Ribner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hillel S. Ribner. Hillel S. Ribner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zucker, Mark, David A. Baran, Luis H. Arroyo, et al.. (2005). De Novo Immunosuppression With Sirolimus and Tacrolimus in Heart Transplant Recipients Compared With Cyclosporine and Mycophenolate Mofetil: A One-Year Follow-Up Analysis. Transplantation Proceedings. 37(5). 2231–2239. 19 indexed citations
2.
Colfer, Harry T., Hillel S. Ribner, Alan H. Gradman, et al.. (1992). Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The American Journal of Cardiology. 70(3). 354–358. 20 indexed citations
3.
Stern, Stephen L., Hillel S. Ribner, Thomas B. Cooper, et al.. (1991). 2-Hydroxydesipramine and Desipramine Plasma Levels and. Journal of Clinical Psychopharmacology. 11(2). 93???98–93???98. 13 indexed citations
4.
Ribner, Hillel S., et al.. (1990). Long‐Term Therapy with Benazepril in Patients with Congestive Heart Failure: Effects on Clinical Status and Exercise Tolerance. The Journal of Clinical Pharmacology. 30(12). 1106–1111. 9 indexed citations
5.
Molteni, Agostino, et al.. (1989). Serum Copper Concentration as an Index of Clinical Lung Injury. PubMed. 258. 273–285. 11 indexed citations
6.
Ribner, Hillel S., et al.. (1985). Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: A hemodynamic-hormonal study. The American Journal of Cardiology. 56(13). 896–904. 71 indexed citations
7.
Kaplan, Kerry, Richard Davison, Michele Parker, et al.. (1985). Frequency of pericardial effusion as determined by M-mode echocardiography in acute myocardial infarction. The American Journal of Cardiology. 55(4). 335–337. 19 indexed citations
8.
Gibson, Thomas, Hillel S. Ribner, & A. Quintanilla. (1984). Effect of acute changes in serum digoxin concentration on renal digoxin clearance. Clinical Pharmacology & Therapeutics. 36(4). 478–484. 12 indexed citations
9.
Askenazi, Joseph, et al.. (1983). Prospective study comparing different echocardiographic measurements of pulmonary capillary wedge pressure in patients with organic heart disease other than mitral stenosis. Journal of the American College of Cardiology. 2(5). 919–925. 9 indexed citations
10.
LeJemtel, Thierry H., Joel A. Strom, Carol S. Maskin, et al.. (1983). Improvement in exercise capacity despite cardiac deterioration: Noninvasive assessment of long-term therapy with amrinone in severe heart failure. American Heart Journal. 106(5). 1042–1047. 11 indexed citations
11.
LeJemtel, Thierry H., Edmund C. Keung, William H. Frishman, Hillel S. Ribner, & Edmund H. Sonnenblick. (1982). Hemodynamic effects of captopril in patients with severe chronic heart failure. The American Journal of Cardiology. 49(6). 1484–1488. 29 indexed citations
12.
Ribner, Hillel S., et al.. (1982). Acute hemodynamic responses to vasodilator therapy in congestive heart failure. Progress in Cardiovascular Diseases. 25(1). 1–42. 30 indexed citations
13.
LeJemtel, Thierry H., Edmund C. Keung, Hillel S. Ribner, et al.. (1980). Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure. The American Journal of Cardiology. 45(1). 123–129. 81 indexed citations
14.
LeJemtel, Thierry H., Uri Elkayam, Hillel S. Ribner, et al.. (1980). Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure*. European Heart Journal. 1(3). 157–163. 13 indexed citations
15.
Keung, Edmund C., Hillel S. Ribner, William Robson Schwartz, Edmund H. Sonnenblick, & Thierry H. LeJemtel. (1980). Effects of Combined Dopamine and Nitroprusside Therapy in Patients with Severe Pump Failure and Hypotension Complicating Acute Myocardial Infarction. Journal of Cardiovascular Pharmacology. 2(2). 113–120. 3 indexed citations
16.
Frishman, William H., Joel A. Strom, Uri Elkayam, et al.. (1979). Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasm. American Heart Journal. 98(3). 393–398. 37 indexed citations
17.
Frishman, William H., et al.. (1979). Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management. American Heart Journal. 98(6). 798–811. 95 indexed citations
18.
Davis, Richard C., Hillel S. Ribner, Edmund C. Keung, Edmund H. Sonnenblick, & Thierry H. LeJemtel. (1979). Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting Enzyme. New England Journal of Medicine. 301(3). 117–121. 219 indexed citations
19.
LeJemtel, Thierry H., Edmund C. Keung, Edmund H. Sonnenblick, et al.. (1979). Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.. Circulation. 59(6). 1098–1104. 166 indexed citations
20.
Rubinstein, L. J., et al.. (1963). Chromophobe adenorna of pituitary gland with subarachnoid metastases. Neurology. 13(10). 836–836. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026